S. Vandamme, Kore Van Mechelen, Hugo Cluckers, V. Van Hoof
{"title":"Nova即时护理测试StatStrip -酮测试在实验室和临床环境中的验证","authors":"S. Vandamme, Kore Van Mechelen, Hugo Cluckers, V. Van Hoof","doi":"10.1097/POC.0000000000000155","DOIUrl":null,"url":null,"abstract":"E ach year in Belgium, 2000 patients are newly diagnosed with type 1 diabetes mellitus (DM) and 23,500 patients with type 2 DM. Diabetic ketoacidosis (DKA) is a severe acute complication of DM, with a prevalence around 30% in type 1 DM and 6% in type 2 DM. Guidelines advocate whole-blood measurement of beta-hydroxybutyrate (βHB) for the management of DKA, making point-of-care testing (POCT) devices for glucose and ketones an important and lifesaving tool. At the request of our emergency department (ED), the POCT hospital meter StatStrip (Nova Biomedical, Waltham, Mass) was installed on trial.","PeriodicalId":20262,"journal":{"name":"Point of Care: The Journal of Near-Patient Testing & Technology","volume":"49 2","pages":"13–14"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of the Nova Point-of-Care Testing StatStrip &bgr;-Ketone Test in a Laboratory and Clinical Setting\",\"authors\":\"S. Vandamme, Kore Van Mechelen, Hugo Cluckers, V. Van Hoof\",\"doi\":\"10.1097/POC.0000000000000155\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"E ach year in Belgium, 2000 patients are newly diagnosed with type 1 diabetes mellitus (DM) and 23,500 patients with type 2 DM. Diabetic ketoacidosis (DKA) is a severe acute complication of DM, with a prevalence around 30% in type 1 DM and 6% in type 2 DM. Guidelines advocate whole-blood measurement of beta-hydroxybutyrate (βHB) for the management of DKA, making point-of-care testing (POCT) devices for glucose and ketones an important and lifesaving tool. At the request of our emergency department (ED), the POCT hospital meter StatStrip (Nova Biomedical, Waltham, Mass) was installed on trial.\",\"PeriodicalId\":20262,\"journal\":{\"name\":\"Point of Care: The Journal of Near-Patient Testing & Technology\",\"volume\":\"49 2\",\"pages\":\"13–14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Point of Care: The Journal of Near-Patient Testing & Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/POC.0000000000000155\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Point of Care: The Journal of Near-Patient Testing & Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/POC.0000000000000155","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Validation of the Nova Point-of-Care Testing StatStrip &bgr;-Ketone Test in a Laboratory and Clinical Setting
E ach year in Belgium, 2000 patients are newly diagnosed with type 1 diabetes mellitus (DM) and 23,500 patients with type 2 DM. Diabetic ketoacidosis (DKA) is a severe acute complication of DM, with a prevalence around 30% in type 1 DM and 6% in type 2 DM. Guidelines advocate whole-blood measurement of beta-hydroxybutyrate (βHB) for the management of DKA, making point-of-care testing (POCT) devices for glucose and ketones an important and lifesaving tool. At the request of our emergency department (ED), the POCT hospital meter StatStrip (Nova Biomedical, Waltham, Mass) was installed on trial.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
